3-benzyl-6-(trifluoromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide-D5; 3,4-Dihydro-3-(phenylmethyl-d5)-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-Dioxide; 3-(Benzyl-d5)-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-Dioxide; Aprinox-d5; Be 724A-d5; Bendrofluazide-d5; (+/-)-Bendroflumethiazide-d5; Bristuron-d5; Centyl-d5; Corzide-d5; FT 81-d5; Flumersil-d5; Naturine-d5; Sinesaline-d5; Sodiuretic-d5; Thiazidico-d5; Urlea-d5
Bendroflumethiazide-d5 is a fully characterized chemical compound used as a reference standard of API Bendroflumethiazide. The standard offered is compliant with regulatory guidelines. Bendroflumethiazide-d5 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1330183-13-5
